Bhatt, D. L., Szarek, M., Pitt, B., Cannon, C. P., Leiter, L. A., McGuire, D. K., . . . Steg, P. G. (2021). Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease. The New England journal of medicine, 384(2), 129-139. https://doi.org/10.1056/NEJMoa2030186
Chicago-Zitierstil (17. Ausg.)Bhatt, Deepak L., et al. "Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease." The New England Journal of Medicine 384, no. 2 (2021): 129-139. https://doi.org/10.1056/NEJMoa2030186.
MLA-Zitierstil (9. Ausg.)Bhatt, Deepak L., et al. "Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease." The New England Journal of Medicine, vol. 384, no. 2, 2021, pp. 129-139, https://doi.org/10.1056/NEJMoa2030186.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.